Majed Faisal Alrumayyan
Papers
1
Total Citations
8
H-Index
1
About
Dr. Majed Faisal Alrumayyan is a dedicated urologic researcher whose work focuses on the evolving surgical management of renal cell carcinoma (RCC) and its impact on patient outcomes. His most-cited study, "Trends in the surgical management of renal cell carcinoma in a contemporary tertiary care setting" (2021, 8 citations), critically examines how the rising incidence of RCC—driven by increased radiological detection—has shifted treatment paradigms. Dr. Alrumayyan highlights the identification of small renal masses as a key factor in improved 5-year survival rates, while probing whether this survival benefit is truly attributable to early detection or other clinical variables. His research underscores the importance of adapting surgical strategies in tertiary care environments to optimize patient prognosis. By analyzing contemporary trends, Dr. Alrumayyan provides valuable insights for clinicians navigating the complexities of RCC management, bridging the gap between diagnostic advances and surgical decision-making. His work contributes to a deeper understanding of how modern urologic practice can enhance outcomes for patients with kidney cancer, making him a thoughtful voice in the ongoing conversation about renal cell carcinoma treatment.
Research Focus
Key Achievements
Top Papers
- 1